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This article gives a detailed description of the procedure the occupational physician uses in interpreting the available scientific data to provide useful
information for prevention of pulmonary diseases related to man-made mineral fibers, particularly lung cancer and mesothelioma. As it is difficult to
reach definite conclusions from human data on the toxicity of specific fibers, an experimental approach is needed. Concerning animal data, we
emphasize that adequate inhalation studies are the "gold standard" for extrapolating to humans. However, experiments using intracavitary injection
or cells in vitro may represent indicative tests for a possible carcinogenic effect. Such tests should be used to assess the intrinsic carcinogenicity of
fibers, but they must be confirmed by adequate inhalation models. Despite the present uncertainties, a proposal is made that could make it possible
to classify fibers according to their toxicologic potential, grading them in accordance with physicochemical parameters, in vitro testing, and animal
experiments. This procedure may be applicable to nonvitreous fibers and to organic fibers. - Environ Health Perspect 102(Suppl 5):31-36 (1994)
Key words: MMMF, diameter, length, carcinogenicity, in vitro, in vivo, animal, human data, classification
Introduction
One of the main objectives of a public
health physician is to transform scientific
data into information useful for prevention
of disease. The occupational physician is a
public health physician who specializes in
occupational health. This presentation will
focus on the consequences of exposure of
workers to man-made vitreous fibers
(MMVF) as seen from the occupational
physician'spoint ofview.
This approach is based on the circum-
stances in which the problem is raised at
the workplace. Usually the occupational
physician is alerted by the presence of
fiber-containing products at some level of
work activity, either because of the intro-
duction ofa new product or because ofany
intervention by a worker on an old fiber-
containing material. The physician then
has to identify the fibers either from infor-
mation obtained from the producer-such
as the health and security data sheet or
product label-or, especially in the case of
old materials, from bulk analysis. The two
main pieces of information that can be
obtained are the chemical identification of
the fibers and their diameter and length
distribution. The next step is to assess the
potential toxicity of the identified fiber.
Here again, the physician uses available
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specific information. However, when such
information is missing or incomplete, he
has to make a risk extrapolation or initiate
a toxicological evaluation. Depending on
the toxicologist's answer, the physician
makes a risk assessment of the situation at
the workplace, taking into account the
level of exposure and the medical status of
the workers. This is possible only if infor-
mation is available on a dose-response rela-
tionship and, particularly, ifthreshold limit
values apply. Finally, he can establish a pre-
vention program.
The aim ofthis presentation is to deter-
mine how the occupational physician could
use the available scientific information
concerning MMVF. To answer this point,
we will discuss the topics concerning fiber
identification, fiber toxicology, and evalua-
tion of fiber-containing products, includ-
ing the possible interpretation of bioper-
sistence relative to each topic. In the light
of this discussion, we propose a systematic
method of assessment of the carcinogenic
potential ofMMVF.
Fiber Identification
A major effort has been made to classify
fibers. However, two questions must be
posed: First, can existing classifications
include any existing or newly developed
commercial fiber? Second, are commercial
and technical classifications compatible
with toxicological data?
Three organizations have proposed clas-
sifications that are in use: The American
Thermal Insulation Manufacturers Associ-
ation (TIMA) has proposed a tree to define
the man-made vitreous fibers, according to
their origin, their physicochemical compo-
sition, and the process of production (1).
The ultimate subdivision of man-made
mineral fibers has been used by the
International Programme on Chemical
Safety (IPCS). However, this classification
is built mainly on a commercial basis, and
some glass fibers of the same chemical
composition are found in different groups.
In other cases fibers with different chemi-
cal compositions can fall into the same cat-
egory (2). The classification used by the
International Agency for Research on
Cancer (IARC) was intended to integrate
toxicological and epidemiological informa-
tion, but it will now be difficult to include
new data relating, for example, to special
purpose fibers (3). None of these classifi-
cations seems completely adapted to a pre-
cise identification of a fiber, or a close
match with toxicological data.
FiberToxicology
Detailed toxicological results are discussed
elsewhere in these proceedings. Here, we
consider only the data that may pose prob-
lems to the occupational physician.
HumanMortalityStudies
Data on mortality have been obtained
exclusively among manufacturing indus-
tries (4-6). They have demonstrated a
small excess of lung cancer in the groups
with the longest duration of exposure, at
least for those exposed to rockwool or slag-
wool and to some superfine glass fibers. It
is, however, very difficult from those data
to distinguish clearly the role of each type
offiber. This is particularly needed for the
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rockwool and slagwool group. In addition,
discussions concerning the influence ofthe
confounding factors on the available results
are not closed (7-10). In any case, two
points have to be reassessed: First, indus-
trial hygiene data suggest that the level of
exposure could be higher among end-users
than among workers in the manufacturing
industry (11); and second, due to the short
survey period on the one hand and, on the
other, the relatively small number of per-
son-years in the groups derived from work-
ers for whom the duration since the
beginning of exposure was more than 30
years, it would not be possible to detect a
low but significant excess risk of mesothe-
lioma on the basis ofthe available data.
MorbidityData
The most pertinent morbidity data are for
workers exposed to insulation wool and
refractory ceramic fibers. Results from the
update of the American "insulation wool"
study still are not available (12,13), while
conflicting results are reported among the
two European and American "ceramic"
cohorts. Preliminary findings of an excess
of pleural plaques in the American cohort
seems to be very important in view of the
relatively short duration ofexposure in that
cohort and the small numbers involved
(14). An updating ofthe European cohort
5 years after the first survey should be very
informative (15).
Human Data onBiopersistence
These data are still difficult to interpret.
On the one hand, in the study made with
the available lung tissue taken at autopsy
from the American cohort, mineral vitre-
ous fibers were so modified that it was
impossible to make a precise identification
of the siliceous fibers (16). On the other
hand, only very preliminary data have been
reported on bronchoalveolar lavage of
ceramic fiber workers. An interesting fea-
ture, however, is the discordance between
human data, which showed a marked
chemical modification of ceramic fibers
that had been deposited in the lung, and
animal data, which did not indicate any
significant modification during a retention
period of2 years (17).
Animal Data
Animal data are still the most detailed data
available, and it is most important to con-
sider the significance ofthe different mod-
els of administration used in animal
experiments-inhalation models, intracavi-
tary models and other mechanistic models.
Inhalation Models
A recent meeting organized by the World
Health Organization emphasized the
importance of adequate inhalation models
for hazard assessment of fibers. To date,
only the recent and ongoing studies carried
out in the Research and Consulting Center
(RCC), Geneva, fulfilled the recommenda-
tions elaborated at this meeting and by the
U.S. Environmental Protection Agency
(18,19). Results already have been pre-
sented. Only a limited number of chemi-
cally different MMVF have been tested,
two very similar glass fibers (MMVF10
and 11) used in commercialized glasswool,
a slagwool (MMVF22) and a rockwool
(MMVF 21) with an intermediate content
of iron oxide. In the ceramic group (RCF
1-4), the list ofcommercial vitreous fibers
is nearly complete. Even what is called an
"after-service fiber" has been tested. In this
group, results from two studies, one pub-
lished in 1987 (20), the other in 1992
(21), show that a very slight shift in fiber
dimension and dose ofa ceramic fiber can
lead to very different results (Table 1).
This finding emphasizes the importance of
standardized criteria for an adequate
inhalation model.
IntracavitayModels
Some of the same fibers as those used in
the RCC (Geneva), study have been tested
in intracavitary models. Even though com-
parison is difficult because fibers were not
of the same origin, the studies reported in
Table 2 using intrapleural administration
have confirmed that ceramic fibers were
more toxic than the others (22-25).
Classification of the results as negative,
doubtful, or positive was made according
to criteria proposed elsewhere (26).
More interesting are the results
observed with intraperitoneal administra-
tion (Table 3). The results show a strongly
positive response from ceramic fiber and
an intermediate response from the rock-
wool fibers tested. These perhaps were not
the same fibers as those used in the inhala-
tion study, but the two results may still be
considered complementary (20, 27-30).
Ifthis estimation is confirmed, it could
increase the significance ofresults obtained
with fibers tested only with intracavitary
models. In the case of"JM special purpose
fine fibers" (Table 4), positive finding of
both intrapleural and intraperitoneal stud-
ies should be considered significant even if
inadequate inhalation studies showed no
carcinogenic effect (20,24,27,29,31-36).
However, available information concerning
the characterization of the fibers used in
those studies is very limited, which makes
it difficult to analyze the precise role of
each parameter ofthe fibers.
Biopersistence
The only reproducible attempt made to
correlate biopersistence rather than durabil-
ity, and biological effect, was in the Geneva
inhalation studies (37,38). The existing
data show that ceramic fibers are more
biopersistent than the glass fibers tested;
rockwool is more biopersistent than slag-
and glasswool and less biopersistent than
ceramic fibers.
Are these results sufficient to draw con-
clusions regarding the role ofbiopersistence
in the biological effects in animal models?
Even ifthe answer to this question is posi-
tive, three other questions remain: Is there
a threshold below which the biopersistence
of the fiber is insufficient to initiate an
irreversible disease? What should be a rec-
ommended experimental model to assess
the level of biopersistence? What are the
predictive parameters of fiber biopersis-
tence (dimensions, chemical composition,
polyatomicstructure, surfacecharacteristics)?
In summary, in spite of the difficulties
of interpreting the current data based on
methods that are either poorly standardized
or not standardized at all, or on incomplete
results, it is still necessary for the occupa-
tional physician to have some basis avail-
able for assessing the carcinogenic potential
of each type of fiber and of any incorpo-
rated substances. In the light ofthe preced-
ing discussion, we propose to develop a
system in two stages that will be valid for
all fibers that might be inhaled, whatever
their origin.
Proposal for a Systematic
Assessment of the
Carcinogenic Potential of a
Fiber Resulting from a Given
Manufacturing Process
BasisfortheClassificationofan
ElementaryFiber
Chemical Characterization. Each process
is defined by the raw material used in it,
and the type offiber that results will have a
chemical composition that will vary within
a fixed range. This variation is related to
the inherent variations found in each batch
of raw material used for a given type of
manufacture. It will be necessary to check
whether the fluctuations in the composi-
tion are liable to produce significant
modification of the biological response.
Meanwhile, it has to be accepted that the
assessment of carcinogenic potential be
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made on a fiber, representative of each
manufacturing process.
Dimensional Characterization. With
the available experimental models, it is only
possible to study fine fibers capable ofpen-
etrating into the bronchoalveolar region of
the lungs. At present, it is accepted that
fibers <1 pm in diameter are the only ones
capable of being inhaled by the rodent
species (rat, hamster) used in inhalation
tests. As a result, only fibers with diameter
<1 pm should be subject to an assessment.
The available data on the model oferionite
have similarly underlined the critical role of
fiber length. The results obtained in
inhalation tests show a drastic reduction in
Table 1. Comparison oftwo chronic inhalation studies ofrefractory ceramicfibers.
LosAlamos (20) Geneva(21)
Dose: 12 mg/m3-200 f/cc Dose: 30 mg/m3-200 f/cc
Scanning electron microscopy Optical microscopy
Mean D: 1.8 pm Mean D: 0.98 pm
GMD: 0.9 pm GMD: 0.82 pm
GML: 25 pm GML: 15.9 pm
L>10 pm:83% L>10 pm: 60%
D <2 pm: 86% D <2 pm: 80% (<1.5pm)
Animal Rat Hamster Rat Hamster
No. ofanimals 55 70 140 140
No. withfibrosis 3 2 4 4
Lung tumors 0 0 20(14.3%) 0
Mesothelioma 0 1(1.4%) 2(1.6%) 60(42%)
Abbreviations: D, diameter; GMD, geometric mean diameter; GML, geometric mean length; L, length.
Table2.Animal data ofintracavitary studies. Summaryoftests byintrapleural injection.a
No. ofgroups No. ofanimals Negativeresultsb Intermediate resultsb Positiveresultsb
Glasswool 4 234 100 0 0
Slagwool 3 120 100 0 0
Rockwool 3 136 100 0 0
Refractory ceramicfiber 1 31 0 100 0
aData from Stanton etal. (22, 23),Wagner etal. (24), and Maltoni and Minardi(25). bPercent ofgroups.
Table3. Animal data of intracavitary studies. Summaryoftests by intraperitoneal injection.!
No. ofgroups No. ofanimals Negative resultsb Intermediateresultsb Positive resultsb
Glasswool 0 0
Slagwool 4 264 100 0 0
Rockwool 9 395 33 33 33
Refractory ceramicfiber 4 156 0 25 75
aData from Smith etal.(20)and Pott etal.(27-30). bPercent ofgroups.
Table 4. Animal data of intracavitary studies: summary of tests on "JM Special Purpose Fibers" by intrapleural and
intraperitoneal injections and inhalation'.
Negative Intermediate Positive
Route ofadminstration No. ofgroups No. ofanimals resultsb resultsb resultsb
Intrapleural injection 9 283 25 25 50
Intraperitoneal injection 22 1028 15 5 80
Inhalation
Inthe rat 8 320 100
Inthe hamster 4 129 100
'Data from Smith et al. (20), Wagner et al. (24), Pott et al. (27,29), Le Bouffant et al. (31,32), McConnell et al. (33),
Gross etal.(34), Mitchell etal.(35), andWagneretal.(36). bPercent ofgroups.
carcinogenic response if the fiber length is
<5 pm. It would therefore seem legitimate
to propose that only fibers .5 pm in length
be subject to assessment.
These two proposals do not exclude the
possibility that in the future an assessment
could be made offibers greater than 1 pm
in diameter or less than 5 pm in length, if
experimental data became available.
Criteriafor Assessment ofBiological
Effects. It seems reasonable to propose a
stage-four-algorithm (Table 5).
First Stage: Physicochemical Criteria.
The physicochemical characteristics, in the
absence ofwhich no carcinogenic effect has
been found in the inhalation model, could
be considered the first criteria ofselection.
A fiber that does not correspond to these
criteria would automatically not need to be
classified. Conversely, a fiber that corre-
sponds to at least one of them would be
classified as "possibly carcinogenic"
[European Community (EC) class 3],
pending the results ofthe subsequent stages
ofthe algorithm. Among the physicochem-
ical criteria, the only one that can be used
at this stage is the dimensional criterion
(diameter <1 pm and length .5 pm).
Subsequently, parameters such as chemical
durability in the appropriate media or the
density of reactive sites capable ofgenerat-
ing free radicals, could be considered. For
each ofthese criteria, it would be necessary
to establish standard methods and vali-
dated threshold levels, beyond which a
parameterwould be considered positive.
Second Stage: Biological Screening
Tests. The response to these tests should
distinguish between a negative response,
which would justify a nonclassification of a
tested fiber, and a positive response, which
would indicate a classification of "possibly
carcinogenic" (EC class 3) pending the
results of the next stages of the algorithm.
Tests, therefore, must be sufficiently reliable
to not give false negatives while at the same
time producing only a minimum of false
positives. Such tests would include, first, cer-
tain in vitro tests, especially tests ofgenotox-
icity, including cell transformation; and
second, in vivo tests by intracavitary injec-
tion.
For each test, methods must be standard-
ized and their sensitivity and specificity
must be established by testing carcinogenic
fibers identified in the inhalation model.
Third Stage: Test by Confirmation
in Animal Experiments. The only test
recognized to date as a reference test for
respiratory carcinogenesis is the inhalation
model meeting all the criteria defined by
WHO (1992). A fiber that is so tested and
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that does not give a significant result
would not be classified. Some authors pro-
pose that in such case the classification of
the preceding stage should be maintained
particularly when the result is not com-
pletely negative, as for example, when there
is fibrosis in the absence ofany significant
excess of tumors. In contrast, a positive
result will lead to a classification of "defi-
nitely carcinogenic in the animal"
(EC class 2).
At present, there is still no consensus
on the method of carrying out and inter-
preting inhalation tests. Must a dose-effect
relationship be observed? How is it possible
to eliminate artifactual responses produced
by overload, which could give false posi-
tives? What is the lower limit of the inter-
nal dose (that is, of fibers retained in the
parenchyma or in the parietal pleura) that
would make it possible to avoid false nega-
tives? How should intermediate responses
be considered, and in particular, nonmalig-
nant pathologies?
Fourth Stage: Epidemiological
Studies. Ifinhalation tests are positive, it is
ethically legitimate to carry out an epi-
demiological follow-up ofthe exposed pop-
ulation. Nevertheless, whatever the quality
ofthese studies, at best they can only corre-
spond to a particular situation of exposure
observed in the manufacturing industry.
For the users ofmaterial containing fibers,
feasibility studies and data already pub-
lished have shown their limitations, such as
multiexposures, or the impossibility of
making a satisfactory characterization of
individual exposure. Further, even in the
production industry, it would be difficult
to have a sufficiently large and homoge-
neous population exposed to one type of
fiber. Larger groupings than those required
for the early stages ofthe algorithm would
be necessary. These factors make it possible
only to take account of positive results-
according to IARC criteria-by applying
them to all the types of fibers that might
have been encountered in the groups of
subjects where a significant risk of respira-
tory cancer has been demonstrated. These
fibers would therefore be classified as "car-
cinogenic in humans" (EC class 1).
In contrast, in the absence ofa positive
result, including the absence of inter-
pretable data, a classification ofthe preced-
ing stage of the algorithm would be
maintained.
Basis forClassification ofaProduct
ContainingFibers
Any product containing fibers must be
considered capable of releasing fibers into
the air at some time during manufacture,
utilization, or destruction. While waiting
for the availability of a standard test capa-
ble ofassessing the risk ofa release offibers
into the air, it is reasonable to base the
assessment on the classified fibers con-
tained in the product.
Products Containing Only One
Chemical Variety ofFibers. Two steps
are required for making an assessment. The
first is to identify fibers <1 pm in diameter
and secondly to determine the proportion
offibers < 1 pm present in the product.
First Stage. The first stage is being
codified. The method proposed by
Schneider et al. (39) makes it possible to
know the precise distribution of fiber
diameters. This distribution is completely
characterized by three parameters: geomet-
ric mean, median, and geometric standard
deviation of the marginal distribution of
the diameter. It is also possible to charac-
terize the proportion of fibers <1 pm in
diameter with the following parameters:
the proportion of the accumulated lengths
of fibers <1 pm in diameter in relation to
the total cumulated length ofall the fibers;
and the proportion of the calculated mass
of fibers (length x diameter x density) of
<1 pm in relation to the total mass of the
sample of the product, including nonfi-
brous particles. This latter parameter also
takes account ofthe presence ofnonfibrous
particles, which can exceed 50% of the
total mass ofparticles.
Second Stage. There is not, at present,
a valid experimental basis for the second
stage. It would be desirable to test experi-
mentally the relationship between the para-
meters determined in the first stage and the
proportion offine fibers liable to be found
Table5.Algorithm offiberclassification (substances).
Question Answers Proposed classification
1) Doesthefiberpossess apriorione ofthecriteria ofrisk? All criteria(confirmed) negative 0 (somewould allocate3bdirectly)
(Certain authorsconsiderthatthesecriteria are unworkable, At leastonecriterion exists 3, pending othertests
and passdirectlytoquestion 2) Results arenegative, butincomplete
2)Was a positive resultobtained with avalidated screening test? All thevalidatedtests are negative 0
At leastonetest ispositive 3, pending inhalation test
Results are negative butincomplete
3) Didvalidated inhalation testgive a positive result? Validated tests negative D(somewould propose maintaining 3forfibers having a
positive screeningtest)
At least onetestpositive 2(somewould prefer3 based onthe strength ofthe
result)
Results are negative but incomplete 3, pending complete inhalation tests
4)Arethere interpretableepidemiological results? Studies negative
Ifthe resultswere reproducible, D
effectivelyadapted tothe risks, and
The resultsapplytoall thefibers likelyto have representative levelsofexposure
been inhaled bythe groups ofsubjectshaving
asignificant response Ifthe results are notreproducible Maintaintheclassification based onexperimental studies
Resultsdoubtful Maintainthe classification based onexperimental studies
Studies positive,according to IARCcriteria 1
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in the aerosol after the samples ofthe prod-
ucts under test have been suspended in air.
While waiting for this validation, and
by analogy with asbestos, it would seem
desirable to determine, as a priority, the
proportion of the mass of fibers <1 pm in
diameter in relation to the total mass of
sample. In conformity with the spirit ofthe
European directive relating to labeling of
preparations, a product containing more
than 1 part per thousand by weight ofclass
2 fibers or one part per 100 ofclass 3 fibers
should be so labeled.
Products Containing Many Fibers or
Other Chemical Substances. The applica-
tion of the "preparation directive of the
EC" would make it possible to choose the
correct label in accordance with the criteria
already established for mixtures of sub-
stances.
Conclusion
The analysis of available data concerning
MMVF shows that there are still a number
of contradictions and gaps. Nevertheless,
the uncertainty that results from these defi-
ciencies must not be used as an excuse by
the occupational physician for delay in set-
ting up a preventive strategy. This is partic-
ularly true for fibers that are already
available commercially.
For this reason, it seems possible to
propose an algorithm of decisions leading
to a classification of fibers and to labeling
ofproducts they contain. This algorithm is
based on available data, on the condition
that an effort is made to standardize the
methods used. It must be usable for already
existing fibers as well as for new fibers in
preparation.
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